BIOC : Summary for Biocept, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 53 mins

Biocept, Inc. (BIOC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.13+0.12 (+6.22%)
As of 2:07PM EST. Market open.
People also watch
SGNLETRMPULMTBIOAPRI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.01
Open2.13
Bid2.10 x 3300
Ask2.12 x 700
Day's Range2.00 - 2.18
52 Week Range0.74 - 5.64
Volume1,777,936
Avg. Volume3,179,134
Market Cap37.36M
Beta2.66
PE Ratio (TTM)-0.82
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 7, 2017

    SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve ...

  • PR Newswire8 days ago

    Biocept Appoints Michael Terry Senior Vice President Commercial Operations

    SAN DIEGO, Feb. 15, 2017 /PRNewswire/ -- Biocept, Inc. (BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces the appointment of Michael Terry to the newly created position of Senior Vice President Commercial Operations. Mr. Terry will lead the Company's commercial organization and oversee Biocept's business development initiatives. "We are very pleased that Mike has joined Biocept, given his significant experience in leading commercial teams and establishing disruptive technologies in the healthcare segment.

  • PR Newswire14 days ago

    Biocept's CEO Issues Letter to Stockholders

    SAN DIEGO, Feb. 9, 2017 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve ...